Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
昨天

DJ Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. $(DGX)$ slid 1.71% to $172.01 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.12% to 5,842.63 and the Dow Jones Industrial Average rising 1.14% to 43,006.59.

This was the stock's second consecutive day of losses.

Quest Diagnostics Inc. closed 3.41% short of its 52-week high of $178.09, which the company achieved on March 3rd.

The stock underperformed when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. $(UNH)$ rose 0.29% to $475.98, IQVIA Holdings Inc. $(IQV)$ rose 1.24% to $185.85, and Centene Corp. $(CNC)$ rose 1.95% to $59.00.

Trading volume (1.5 M) eclipsed its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 05, 2025 17:09 ET (22:09 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10